Detailed answers about INTHERA PHARMACEUTICALS LIMITED, including incorporation, status, business activity, and accounts information.
When was INTHERA PHARMACEUTICALS LIMITED founded?
INTHERA PHARMACEUTICALS LIMITED was officially incorporated on 10 April 2025 and is registered under company number 16378742. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is INTHERA PHARMACEUTICALS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of INTHERA PHARMACEUTICALS LIMITED?
INTHERA PHARMACEUTICALS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does INTHERA PHARMACEUTICALS LIMITED do?
INTHERA PHARMACEUTICALS LIMITED operates in the following sectors: 46460 - Wholesale of pharmaceutical goods, 46750 - Wholesale of chemical products, 52102 - Operation of warehousing and storage facilities for air transport activities, 82920 - Packaging activities. These SIC codes provide insight into the company's business activities and industry focus.
What is INTHERA PHARMACEUTICALS LIMITED's registered address?
The registered office address of INTHERA PHARMACEUTICALS LIMITED is 21 ELLIS STREET, LONDON, LONDON, UNITED KINGDOM, SW1X 9AL. This is the official address filed with Companies House for legal and statutory correspondence.
Is INTHERA PHARMACEUTICALS LIMITED financially stable?
Financial accounts for INTHERA PHARMACEUTICALS LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.